ABOUT US

LaserLeap Technologies was founded to address the need for a painless method of delivering drugs through the skin and to promote faster, more effective treatments. Two decades of research with lasers and ultrasound resulted in technology that combines affordable lasers with innovative materials capable of making our skin permeable to drugs and cosmetics in a safe, painless, and effective manner. LaserLeap opened for business in 2011, in Coimbra, Portugal, focused in the development of a method for permeating skin and allow the delivery of cosmetics and drugs, along with anesthetics, skin cancer drugs, vaccines and biotechnology drugs.

MISSION AND VALUES

LaserLeap Technologies offers a painless, efficient solution for delivering cosmetics and drugs through the skin. Its mission is to develop a safe, simple, affordable solution for the global transdermal drug-delivery market.

FOUNDERS

Luís Arnaut

Chairman

Carlos Serpa

Chef Executive Officer

Gonçalo de Sá

Chief Operations Officer

LUÍS ARNAUT

Full Professor at the Faculty of Sciences and Technology, University of Coimbra, where he completed his Ph.D. in 1988.

Over 20 years of experience with lasers and photoacoustic research; around 100 articles in international scientific journals; 200 citations of his scientific works; the lead on 11 competitive international projects (around €10 million) over the past 20 years.

Co-inventor of two patents in the field of photodynamic therapy and of one patent in active transdermal delivery of drugs. Founder of a pharmaceutical company (Luzitin).

2011 INVENTA prize, for the best Portuguese patent from 2001-2010, awarded by the Portuguese Patent Office (INPI).

Founder and shareholder of LaserLeap Technologies, SA.

CARLOS SERPA

Researcher at the Faculty of Sciences and Technology, University of Coimbra. Ph.D. in Chemistry from the University of Coimbra.

Over 12 years of experience in fundamental and applied research; 10 years of experience in Photoacoustics; having published 30 articles in international scientific journals in the field of photo-induced phenomena and light-matter interaction.

Co-inventor of a patent on active transdermal delivery.

Experience managing R&D projects, high-tech laboratories and entrepreneurship courses.

Founder and shareholder of LaserLeap Technologies, SA.

GONÇALO DE SÁ

Ph.D. from the Faculty of Sciences and Technology, University of Coimbra.

Specialist in transdermal drug delivery systems, in particular active transdermal delivery.

Co-inventor of a patent on active transdermal delivery.

Multiple courses on entrepreneurship, business economics and high-tech entrepreneurship, and business aspects in photonics, at the University of Coimbra, Vrije University of Brussels, and Portuguese Catholic University.

Founder and shareholder of LaserLeap Technologies, SA.